AFTER BEF FORUM
> ATTENDEES
> INVESTORS
> PRESENTERS
​> RISING STARS
> EXHIBITORS
​> SPONSORS
​> ​SUPPORTERS

PARTICIPATING COMPANIES INCLUDE:

2908.Expeditions
4BIO Capital
AbbVie Ventures
AbbVie, Inc.
Abingworth LLP
Accequa AB
Acme Investments SPF Sarl
ActeaVentures
Actelion, a Janssen Pharmaceuticals Company of Johnson & Johnson
Acticor Biotech SAS
Actinium Pharmaceuticals, Inc.
ACXIT Capital Management GmbH
Adare Pharmaceuticals S.r.l.
Adrenomed AG
Advent France Biotechnology
Advent Life Sciences
aescuvest international GmbH
Affibody AB
Agile Capital Markets
Aglaia BioMedical Ventures
aiNET GmbH
Alentis Therapeutics AG
Alibion GmbH
Allecra Therapeutics GmbH
Allelica
ALSA Holdings
Alta Life Sciences
AltA-ZuZ Therapeutics Ltd.
Altitude Investment Management, LLC
aMoon Fund
Amryt Pharma Plc
Anagenesis Biotechnologies
ANDERA Partners
Anergis SA
Anima Biotech, Inc.
Anjarium Biosciences AG
Anocca AB
Antagonis Biotherapeutics GmbH, former Principal of Venture Investments, JJDC
Apollo Ventures
AptaTargets S.L.
Aqsens Health Ltd.
Araris Biotech AG
Ares Genetics GmbH
Arix Bioscience Plc.
Arrowfield Capital
ARTO AG
Ascenion GmbH
Askel Healthcare Ltd.
Asklepios Advisors
ATGN Consulting
Athira Pharma, Inc.
ATRIVA Therapeutics GmbH
Avicenna Oncology GmbH
Àvida Biotech, S.L.
Avillion LLP
Axicos AG
B.O. Consulting GmbH
b2Quant, Lda.
Bachem AG
Banque Profil de Gestion SA
BaseLaunch
Bavarian Capital Management
BB Pureos Bioventures
Be Sure Healthcare B.V.
BeiGene Ltd.
Bellevue Asset Management AG
Belsize Asset Management GmbH
Bergmann zur Hausen & Cie. GmbH
BERNINA BioInvest Ltd
BetaGlue Technologies SpA
Biel Glasses
Bio Capital Impact Fund
Bio Medi Gene Ventures
BioBac BioValley Business Angel Association
BioEcho Life Sciences GmbH
BioGeneration Ventures
Biognosys AG
BioLineRx Ltd.
BioM Biotech Cluster Development GmbH
BioMedPartners AG
BioNTech SE
BioSeed Capital
BioStart Consulting GmbH
Biotech Alliances International, Inc.
BioValley Basel & Suterscience, LLC
BiovelocITA S.r.l.
BioVersys AG
Bird & Bird LLP
Bloomberg L.P.
Boehringer Ingelheim International GmbH
Boehringer Ingelheim Venture Fund GmbH
BOHE Angel Fund
Böhler Life Science Advice
Bone Therapeutics SA
Bootstrap Europe
​Boston Consulting Group
Boston Pharmaceuticals
Bpifrance
Breslin AG
Bridge Valley Venture LLP.
BROTHERS & PARTNERS EUROPE
Bryan, Garnier & Co
Canica International AG
Cantargia AB
Canvirex AG
Capital Grand Est
Capricorn Partners NV
Cardior Pharmaceuticals GmbH
CaSRevolution S.r.l.
Catalyze B.V.
CBC Group (C-Bridge Capital)
CDR-Life AG
Cederberg GmbH
Cellestia Biotech AG
Chang Jiang Business School
Charles River Laboratories
ChinaBio Group
Clarus Capital Group AG
Click Therapeutics, Inc.
CoFeS China Ltd.
Concenter BioPharma Ltd.
Convergence Partners AG
Corion Biotech S.r.l.
Coulter Partners
Covance, Inc.
Crescendo Biologics Ltd.
Cresset Group
Csendes Consulting
CSL Behring
Cukierman & Co. Life Sciences
Cullgen, Inc.
Cutiss AG
Cyxone AB
Daiichi Sankyo Europe GmbH
Dalriada Drug Discovery Inc.
DCPrime B.V.
DDF Ventures B.V.
Delin Ventures Ltd.
Delta 4
Deltec International Group
Dementia Discovery Fund
DHBW Lörrach
Diadem S.r.l.
Digital Networks Plc.
Dr. Pfleger Arzneimittel GmbH
Dyadic International, Inc.
EA pharma Co., Ltd.
Earlybird Venture Capital
Economic and Trade Department, Embassy of Israel
e-Fásli
EG Capital Advisors
EIT Health e.V.
Eli Lilly and Company
Emerging Technology Partners, LLC (ETP)
Endotelix
EpiEndo Pharmaceuticals
EpimAb Biotherapeutics GmbH
Ernst & Young AG
Esper Bionics
Esperante Ventures
Eudendron S.r.l.
European Investment Bank
EVA Basel
Evotec AG
F2G Ltd.
Faron Pharmaceuticals Ltd.
FasTeesH
Forbion
Francois C. Martin LLC.
Fraser Finance LLP
Freeline Therapeutics
FreeMind Group
Gain Therapeutics SA
Galilee Cannabis Consortium
Genclis SA
GeNeuro SA
Genextra S.p.A.
GenSearch Switzerland GmbH
Geron Corporation
Gigabases Switzerland AG
Gilde Healthcare Partners
Gimv
GlaxoSmithKline
Global Investment Bridge AG
GLSV GmbH
GlyCardial Diagnostics
GO CAPITAL
Goetzpartners Securities
Grabulovski Consulting Services GmbH, ex Co-Founder & CSO of Covagen
Gravitas Capital LLC
GrowthCube Partners LLC
Guggenheim Securities, LLC
H.C. Wainwright & Co., LLC
Hadean Ventures
HAYA Therapeutics
HBM Partners AG
Health Passion Fund
HealthCap
HealthCare Royalty Partners
Hempiness
Hestia Investments
High-Tech Gründerfonds Management GmbH
Hoffmann & Co AG
HOOKIPA Pharma, Inc.
humanITcare
i&i Prague
IATI (Israel Advanced Technology Industries)
ICF Consult (Switz.)
Idana (a product of Tomes GmbH)
IGEM Therapeutics Ltd.
Ignite Capital Partners, Inc.
Ihang Equity Investment
IKU
Illumina Accelerator
Illumina Ventures
Image Analysis Group
Imcyse SA
IMI Consulting GmbH
ImmuCon i.G.
Immunethep, SA
Immunicum AB
Inbio Ventures
Indaco Venture Partners SGR SpA
Indelve
Independed - SK
Independent - HK
Independent - LB
Independent - LC
Independent - RM
Industrifonden
Inflectis Biosciences
Informa Plc.
Inkef Capital B.V.
Innogest Capital
Innovate Biopharmaceuticals, Inc.
Inositec AG
Instinctif Partners Ltd.
International IB High School
InveniAI Corporation
Inveready Asset Management
investiere Verve Capital Partners

IO Biotech ApS
IPDx
IPF Partners
iSD Immunotech ApS
Italian Trade Agency (ITA)
JIH Vermögensverwaltungs GmbH
Jina Ventures, Inc.
Johnson & Johnson
Johnson & Johnson Innovation
Johnson & Johnson Innovation | Janssen Business Development
Joint Polish Investment Fund
Julius Baer Ltd.
Junewicz & Co., Inc.
Justin Stindt Consulting GmbH
Kanton Basel-Stadt
Karyopharm Therapeutics, Inc.
Kempen & Co
Kinarus AG
KIZOO Technology Capital GmbH
KPMG
Kreos Capital Management (UK) Ltd.
Kronos Advisors
Kupando GmbH
Kuros Biosciences AG
Ladenburg, Thalmann & Co., Inc.
LBBW Venture Capital
Leads To Development
Life Length, S.L.
Life Science Animation
LifeCare Partners
LifeSci Advisors
Lifetag Diagnostics
LimmaTech Biologics AG
Lipum AB
LMU Munich
Locust Walk
LOGSCALE Venture Partners
Lombard Odier
Longitude Capital
Lonza Pharma & Bitoech
Loro co.
LS CancerDiag Oy
LSP
Lundbeckfonden Ventures / Lundbeckfonden Emerge
LyGenesis, Inc.
M Ventures
M&G Advisors
Macrophage Pharma
MainFirst Bank AG
Marinomed Biotech AG
Marker Therapeutics, Inc.
MedAware
Medical Simulation Technologies Sp. z o.o.
Medicxi
MedinCell
medme
MedVest UK LLP
Memo Therapeutics AG
MercachemSyncom
Merck KGaA
Metellus AG
MetrioPharm AG
Metys Pharmaceuticals AG
mindcoa.ch GmbH
MinervaX ApS
Mirabaud Securities Ltd.
Modra Pharmaceuticals B.V.
Momentum Biotech
Mor Research Applications Ltd.
Mosaic Software S.r.l./PatchAI
MSD
Mymetics SA
MyWay Genetics S.r.l.
NanoDimension Ventures
Nasdaq OMX
NBE-Therapeutics Ltd.
Nerum Pharmaceuticals AG
NEURALTIDE
Neuraxpharm
Neurimmune AG
NeuroVive Pharmaceutical AB
New Science Global Healthcare Fund
Nextech Invest Ltd.
Nomi Biotech Corporation
Norgine Ventures
NoToVir S.r.l.s.
NovaDiscovery
NovaGo Therapeutics AG
Novaremed AG
Novartis International AG
Novartis Oncology
Novartis Venture Fund
Novo Holdings A/S
Novo Nordisk A/S
NxR Biotechnologies GmbH
O2H Ventures Ltd.
Omnix Medical Ltd.
Optimum Strategic Communications
OrbiMed Advisors LLC
Orexo AB
Oryzon Genomics S.A.
Otsuka Pharmaceutical
Otsuka Pharmaceutical Europe Ltd.
Oxiros
OxRegen
OxStem Limited
Oxurion NV
Oxyrane
Panakes Partners SBMT SpA
PANOXYVIR Ltd.
Parkinson’s UK
Partner International, Inc.
PDC*line Pharma SA
Perseo Pharma AG
Pfizer, Inc.
PharmaBiome AG
PharmaKrysto Ltd.
Pharmaleads SA
PharmaVentures Ltd.
Pharmstandard Ventures
Phi Pharma SA
PIQUR Therapeutics AG
PKvitality
Plasfer S.r.l.
PMV NV
Polyneuron Pharmaceuticals AG
Portugal Ventures SCR, SA
Positive Capital
Premier Research
Primex Pharmaceuticals AG
Privateq Advisors AG
ProClinical Ltd.
Quan Capital
Quotient Sciences Ltd.
RBV Capital
RECARDIO Inc.
Redalpine Venture Partners AG
Research Toxicology Centre (RTC)
Rheomuco by Rheonova
RhoVac AB
Roche Venture Fund
Roivant Sciences GmbH
RSA Consulting Ltd.
Ruffena Capital Ltd.
Sanofi
Saverna Therapeutics
Schroder Adveq
Schwarz Financial Communication
SciCann Therapeutics, Inc.
Senolytic Therapeutics, Inc.
Servier
Seventure Partners SA
SiBreaX AG
Silence Therapeutics Plc.
Silicon Valley Bank
Sirana Pharma GmbH
SIX Swiss Exchange
Smart EpiGenetX
Sofinnova Partners SA
Soluventis Nanotherapeutics GmbH
Somnox
Sosei Heptares
SOTIO a.s.
Sourcia B.V.
Staatz Business Development & Strategy
STALICLA S.A.
STERO Biotechs Ltd.
Stifel Financial Corp.
Stratos Bio
Summit Partners Limited
Sunstone Life Science Ventures A/S
Sutura Therapeutics Ltd.
SVB Leerink
Swedbank Robur AB
Swiss Biotech Association
Syncrosome
Synendos Therapeutics AG
Syneos Health
SyNoesis Therapeutics
T3 Pharmaceuticals AG
TADA Medical AB
TargImmune Therapeutics AG
Teijin Pharma Ltd
The German Accelerator Life Sciences (GALS)
The Janssen Pharmaceutical Companies of Johnson & Johnson
The Royal College of Surgeon in Ireland
Themis Bioscience GmbH
TherapySelect
TheraVenture GmbH
TiVenture
TolerogenixX GmbH
TOLREMO Therapeutics AG
Topadur Pharma AG
Torreya Partners (Europe) LLP
Torreya Partners, LLC
Transparency Life Sciences
Trinitas Capital
TruVenturo GmbH
Tubulis GmbH
Turos Capital AG
TVM Capital Life Science
TWC Pharma Consulting GmbH
UGA Biopharma GmbH
Ultivue, Inc.
University Hospital Regensburg
University of Turin
University of Zurich
Valor Management S.A.
valuationLAB AG
VAXXIT S.r.l.
V-Bio Ventures
Ventac Partners GmbH
Venture Valuation AG
Versameb Ltd.
Versant Ventures
Versantis AG
Vesalius Biocapital Partners Sàrl
Vetter Pharma International GmbH & Co. KG
VI Partners AG
Viopas Partners
Virometix AG
VISCHER AG
Vivant Holdings
Vogel BioC
W Heindl Unternehmensberatung
Wellington Partners
Wello.ai
Whale Bay Capital
Wille AG
Wilson Sonsini Goodrich & Rosati
Xeraya Capital
XOventure GmbH
Yafo Capital
Yorkville Advisors, LLC
Ysios Capital Partners
ZKB (Zürcher Kantonalbank)
Zmed Laser Ltd.

* More to be announced. Last updated on 23.09.2019